Leucine Rich Repeat Containing 20 (LRRC20) Antibody (FITC)
169€ (20 µg)

169€ (20 µg)
Por favor contáctenos para obtener información detallada sobre el precio y disponibilidad.
935106861
info@markelab.com
name
Leucine Rich Repeat Containing 20 (LRRC20) Antibody (FITC)
category
Primary Antibodies
provider
Abbexa
reference
abx309052
Descripción del producto
LRRC20 Antibody (FITC) is a Rabbit Polyclonal against LRRC20 conjugated to FITC.
Documents del producto
Instrucciones
Data sheet
Especificaciones del producto
NCBI Accession | NP_001265140.1, NM_001278211.1 |
Alias | LRRC20 |
Availability | Shipped within 5-10 working days. |
Background | Antibody anti-LRRC20 |
Buffer | 0.01 M PBS, pH 7.4, 0.03% Proclin-300 and 50% Glycerol. |
Category | Primary Antibodies |
Clonality | Polyclonal |
Conjugation | FITC |
Dry Ice | No |
Form | Liquid |
Gene ID | 55222 |
Host | Rabbit |
Immunogen Target | Leucine Rich Repeat Containing 20 (LRRC20) |
Isotype | IgG |
Name | Leucine Rich Repeat Containing 20 (LRRC20) Antibody (FITC) |
Price | 169 |
Provider | Abbexa |
Purification | Purified by Protein G. |
Purity | > 95% |
Reactivity | Human |
Recommended Dilution | Optimal dilutions/concentrations should be determined by the end user. |
Reference | abx309052 |
Size 1 | 20 µg |
Size 2 | 50 µg |
Size 3 | 100 µg |
Size 4 | 200 µg |
Size 5 | 1 mg |
Status | RUO |
Storage | Aliquot and store at -20°C. Avoid exposure to light. Avoid repeated freeze/thaw cycles. |
UniProt ID | Q8TCA0 |
Descripcion del producto en español
Background en español
LRRC20 is a protein with emerging roles in immune regulation and cellular communication, primarily expressed in tissues with high immune cell activity such as lymph nodes and spleen studies indicate LRRC20 participates in modulating cytokine responses and immune cell adhesion through its interactions with extracellular matrix proteins and cell surface receptors its expression has been linked to the regulation of inflammation particularly in chronic conditions where it influences macrophage and T-cell activity LRRC20 has also been implicated in cancer immunology with evidence suggesting it may facilitate immune evasion by altering cytokine networks and immune checkpoint pathways although its precise molecular mechanisms remain unclear research is exploring its potential involvement in signal transduction pathways related to immune synapse formation its expression patterns and interactions suggest a role in maintaining immune homeostasis and responses to infections but further studies are required to characterize its function and therapeutic potential in immune and inflammatory disorders
Related Products

anti- LRRC20 antibody
Ver Producto
Leucine Rich Repeat Containing 20 (LRRC20) Antibody
LRRC20 Antibody is a Rabbit Polyclonal against LRRC20.
Ver Producto
Leucine Rich Repeat Containing 20 (LRRC20) Antibody (HRP)
LRRC20 Antibody (HRP) is a Rabbit Polyclonal against LRRC20 conjugated to HRP.
Ver Producto